About the Authors

Katharina Pomej

Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria

Bernhard Scheiner

Roles Conceptualization, Formal analysis, Writing – review & editing

Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria

Lukas Hartl

Roles Data curation, Writing – review & editing

Affiliations Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria

Lorenz Balcar

Roles Data curation, Writing – review & editing

Affiliations Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria

Tobias Meischl

Roles Writing – review & editing

Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria

Mattias Mandorfer

Roles Writing – review & editing

Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria

Thomas Reiberger

Roles Writing – review & editing

Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria, Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria

Christian Müller

Roles Writing – review & editing

Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria

Michael Trauner

Roles Writing – review & editing

Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria

Matthias Pinter

Roles Conceptualization, Data curation, Formal analysis, Supervision, Writing – original draft, Writing – review & editing

matthias.pinter@meduniwien.ac.at

Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria

Competing Interests

K.P. has nothing to declare; B.S. received travel support from Gilead, Ipsen and AbbVie; L.H. has nothing to declare; L.B. has nothing to declare; T.M. has nothing to declare; M.M. served as a speaker and/or consultant and/or advisory board member for AbbVie, Bristol-Myers Squibb, Collective Acumen, Gilead, and W. L. Gore & Associates and received travel support from AbbVie, Bristol-Myers Squibb, and Gilead; T.R. received travel support from Gilead, Roche, MSD, and Gore; grant support from Gilead, Abbvie, Philips, Boehringer Ingelheim, Phenex Pharmaceuticals, and Gore, and served as a consultant for MSD, Gilead, Abbvie, and Boehringer Ingelheim; C.M. has nothing to declare; M.T. received grant support from Albireo, Cymabay, Falk, Gilead, Intercept, MSD, and Takeda, honoraria for consulting from BiomX, Boehringer Ingelheim, Falk, Genfit, Gilead, Intercept, Janssen, MSD, Novartis, Phenex, Regulus and Shire, speaker fees from BMS, Falk, Gilead, Intercept and MSD, as well as travel support from Abbvie, Falk, Gilead and Intercept; M.P. is an investigator for Bayer, BMS, Lilly, and Roche; he received speaker honoraria from Bayer, BMS, Eisai, Lilly, and MSD; he is a consultant for Bayer, BMS, Ipsen, Eisai, Lilly, MSD, and Roche; he received travel support from Bayer and BMS. This does not alter our adherence to PLOS ONE policies on sharing data and materials.